Growth Metrics

Barinthus Biotherapeutics (BRNS) Exchange Rate Effect (2020 - 2026)

Barinthus Biotherapeutics (BRNS) has disclosed Exchange Rate Effect for 7 consecutive years, with -$1.4 million as the latest value for Q1 2026.

  • For Q1 2026, Exchange Rate Effect fell 143.84% year-over-year to -$1.4 million; the TTM value through Mar 2026 reached $2.6 million, up 65.72%, while the annual FY2025 figure was $7.0 million, 447.01% up from the prior year.
  • Exchange Rate Effect hit -$1.4 million in Q1 2026 for Barinthus Biotherapeutics, down from $418000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $6.2 million in Q3 2024 and bottomed at -$7.3 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $352823.5, with a median of $418000.0 recorded in 2025.
  • Year-over-year, Exchange Rate Effect skyrocketed 1604.17% in 2022 and then crashed 754.81% in 2024.
  • Barinthus Biotherapeutics' Exchange Rate Effect stood at $5.7 million in 2022, then tumbled by 80.41% to $1.1 million in 2023, then crashed by 754.81% to -$7.3 million in 2024, then surged by 105.69% to $418000.0 in 2025, then crashed by 423.44% to -$1.4 million in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at -$1.4 million, $418000.0, and -$1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.